CD4 and acute myeloid leukemia: The CD4CAR lentiviral vector was used to design third-generation CAR-NK cells (CD28.BB), which successfully eradicated CD4-expressing AML cells in vitro and demonstrated robust antileukemic activity in a CD4+ AML xenograft mouse model [173].